Trials / Completed
CompletedNCT04107779
Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS
A Randomized, Open Label, Parallel Group Study in Adult Smokers to Evaluate Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to Using JUUL Electronic Nicotine Delivery Systems With Two Different Nicotine Concentrations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 279 (actual)
- Sponsor
- Juul Labs, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Open Label, Parallel Group Study in Adult Smokers to Evaluate Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to using JUUL Electronic Nicotine Delivery Systems With Two Different Nicotine Concentrations
Detailed description
Previous studies and data reported in the literature support that Electronic Nicotine Delivery Systems (ENDS) have less toxicant exposure. This study will serve as a clinical evaluation of exclusive-use of selected JUUL ENDS in 2 different nicotine concentrations (5%, 3%), with the purpose of gaining data to support the hypothesis that exclusive-use of JUUL ENDS over the course of 6 days will result in a significant reduction in toxicant exposure compared to combustible cigarettes. This will be a randomized, open label, parallel group study in adult smokers to be conducted at up to 5 sites in the United States. Changes in Biomarkers of Exposure (BoEs) from baseline when using four JUUL ENDS with 2 different nicotine concentrations (5%, 3%) relative to Usual Brand (UB) of combustible cigarettes and a study group abstaining from any tobacco/nicotine product use will be assessed in this study. JUUL ENDS will be used either exclusively or partially (dual-use), with subjects in the dual-use group using both JUUL 5% ENDS (choice of Virginia Tobacco (VT), Mint, Menthol or Mango flavors) and UB of combustible cigarettes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Switch from UB of Combustible Cigarette to JUUL 5% Virginia Tobacco ENDS | JUUL 5%, ENDS for 6-days in confinement |
| OTHER | Switch from UB of Combustible Cigarette to JUUL 3% Virginia Tobacco ENDS | JUUL 3%, ENDS for 6-days in confinement |
| OTHER | Switch from UB of Combustible Cigarette to JUUL 5% Mint ENDS | JUUL 5%, ENDS for 6-days in confinement |
| OTHER | Switch from UB of Combustible Cigarette to JUUL 3% Mint ENDS | JUUL 3%, ENDS for 6-days in confinement |
| OTHER | Switch from UB of Combustible Cigarette to JUUL 5% Menthol ENDS | JUUL 5%, ENDS for 6-days in confinement |
| OTHER | Switch from UB of Combustible Cigarette to JUUL 3% Menthol ENDS | JUUL 3%, ENDS for 6-days in confinement |
| OTHER | Switch from UB of Combustible Cigarette to JUUL 5% Mango ENDS | JUUL 5%, ENDS for 6-days in confinement |
| OTHER | Switch from UB of Combustible Cigarette to JUUL 3% Mango ENDS | JUUL 3%, ENDS for 6-days in confinement |
| OTHER | Switch to Dual-use of JUUL 5% and UB of Combustible Cigarette | Combination use of JUUL 5% (Virginia Tobacco, Mint, Menthol or Mango flavored) and usual brand combustible cigarettes for 6-days in confinement |
| OTHER | Tobacco/Nicotine Abstention | No smoking for 6-days in confinement. |
| OTHER | Usual Brand of cigarettes | Continue smoking UB for 6-days in confinement. |
Timeline
- Start date
- 2019-09-17
- Primary completion
- 2020-02-17
- Completion
- 2020-06-24
- First posted
- 2019-09-27
- Last updated
- 2020-07-28
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04107779. Inclusion in this directory is not an endorsement.